SCHEMBL22997683

SCHEMBL22997683

CSN1CCC(Nc2ncc(C(F)(F)F)c(-c3cn(-c4ccc(CN5CCC5)cc4Cl)cn3)n2)C(F)C1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CCNE1 P24864 14/20 0.40
▸ CDK2 P24941 14/20 0.40
▸ CCND1 P24385 11/20 0.40
▸ CDK6 Q00534 11/20 0.40
▸ CDK4 P11802 7/20 0.40
▸ CCND3 P30281 7/20 0.40
▸ CCNT1 O60563 6/20 0.40
▸ CDK9 P50750 6/20 0.40
▸ CDK1 P06493 5/20 0.40
▸ CCNB1 P14635 5/20 0.40
▸ CDK7 P50613 4/20 0.40
▸ CCNH P51946 4/20 0.40
▸ MNAT1 P51948 4/20 0.40
▸ CCNK O75909 3/20 0.34
▸ CDK12 Q9NYV4 3/20 0.34
▸ LRRK2 Q5S007 1/20 0.33
▸ PDE2A O00408 1/20 0.33
▸ PHGDH O43175 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22997873 0.90 CCNE1 (0.47) CCNE1CDK2CCND1CDK6CDK4
SCHEMBL23001272 0.90 CCNE1 (0.40) CCNE1CDK2CCND1CDK6CDK4
SCHEMBL22997880 0.89 CCNE1 (0.47) CCNE1CDK2CCND1CDK6CDK4
SCHEMBL29821169 0.88 CCNE1 (0.51) CCNE1CDK2CCND1CDK6CDK4
SCHEMBL30449178 0.88 CCNE1 (0.51) CCNE1CDK2CCND1CDK6CDK4
SCHEMBL22976999 0.88 CCNE1 (0.51) CCNE1CDK2CCND1CDK6CDK4
SCHEMBL22977146 0.88 CCNE1 (0.51) CCNE1CDK2CCND1CDK6CDK4
SCHEMBL22997666 0.85 CCNE1 (0.37) CCNE1CDK2CCND1CDK6CDK4
SCHEMBL22997677 0.84 CCNE1 (0.46) CCNE1CDK2CCND1CDK6CDK4
SCHEMBL22997871 0.84 CCNE1 (0.46) CCNE1CDK2CCND1CDK6CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021030537-A1 IMIDAZOLYL PYRIMIDINYLAMINE COMPOUNDS AS CDK2 INHIBITORS INCYTE CORPORATION (US) 2021-02-18 — — WO disclosed
Send feedback